Does Cutaneous Lupus Raise Neonatal Lupus Risk in Pregnancy?

Having cutaneous lupus (skin lupus) does not mean your baby will be born with adult lupus. Most women with cutaneous lupus erythematosus (CLE) have healthy pregnancies and healthy babies. When it comes to your baby’s health, the main concern is whether you carry specific antibodies called Anti-Ro/SSA and Anti-La/SSB. These antibodies can cross the placenta and carry a risk of causing neonatal lupus in your baby ^[1]. The risk of antibody-mediated neonatal lupus is driven by these specific antibodies, not merely by the fact that you have skin lupus ^[1]. Because of this, it is highly recommended to undergo preconception screening to check your antibody status, review your medications, and allow your care team to plan for any necessary monitoring ^[2][3].

What is Neonatal Lupus?

Neonatal lupus is not the same as the lupus adults get. It is usually a temporary condition caused by the mother’s autoantibodies (immune system proteins that mistakenly target the body’s own tissues) passing to the developing fetus ^[1]. It does not mean the child will go on to develop systemic lupus later in life ^[4].

Neonatal lupus can affect the skin, liver, and blood counts ^[5]. The overall risk of any manifestation of neonatal lupus in a first pregnancy is about 2% ^[6]. The most common physical sign is a skin rash, which may be present at birth or appear weeks later, especially after exposure to sunlight ^[4]. This rash usually resolves on its own within about six months as the mother’s antibodies leave the baby’s system, though it can sometimes take longer, and any persistent skin findings should be evaluated by a pediatrician ^[4].

However, in rare cases, these antibodies can affect the baby’s developing heart, causing a more serious and potentially permanent condition known as congenital heart block (CHB) ^[7]. CHB slows the baby’s heartbeat and sometimes requires a pacemaker ^[6]. For a mother who carries Anti-Ro/SSA antibodies and has not had a previously affected child, the risk of having a baby with congenital heart block is approximately 1% to 2% ^[8][9]. If a mother has previously had a child with neonatal lupus or congenital heart block, the risk of CHB in a future pregnancy increases to about 12% to 18% ^[10][11].

Does Having Cutaneous Lupus Change the Risk?

The risk of neonatal lupus is determined by the presence of Anti-Ro/SSA and Anti-La/SSB antibodies, rather than your specific diagnosis ^[1]. Research shows that mothers of babies born with neonatal lupus can have various connective tissue diseases, and about half of them do not have any symptoms of autoimmune disease at all during their pregnancy ^[1]. Therefore, having skin-limited lupus (CLE) instead of systemic lupus (SLE) does not necessarily lower the neonatal lupus risk to your baby if you carry the antibodies ^[1].

It is also important to recognize that while the antibodies drive the neonatal lupus risk, other factors related to lupus—such as kidney involvement, active systemic inflammation, or high blood pressure—can independently affect your overall pregnancy risk for complications like preeclampsia or preterm birth ^[3].

The Importance of Preconception Screening

Because the presence of these antibodies is the main risk factor for neonatal lupus, preconception counseling is a critical step in family planning ^[2]. Before you start trying to get pregnant, your care team should perform a comprehensive assessment ^[3]:

• Antibody Testing: Your doctor will run blood tests to check your Anti-Ro/SSA and Anti-La/SSB status ^[3].
• Systemic Evaluation: Your care team will want to check for any signs that your cutaneous lupus might be progressing to systemic lupus or affecting your organs. This evaluation typically includes a clinical review of your symptoms, blood pressure checks, complete blood counts, serum creatinine, and a urinalysis (including urine protein assessment) ^[12][3].
• Medication Review: Do not stop or change any of your medications without consulting your prescribing doctor. Some medications used to treat skin lupus—such as oral retinoids, methotrexate, and mycophenolate—are not safe for pregnancy and require a specific washout period before you conceive ^[2]. However, other medications like azathioprine or topical treatments may be considered safe, and abruptly stopping them could cause a dangerous lupus flare.
• Hydroxychloroquine (Plaquenil): If you take hydroxychloroquine, it is generally continued during pregnancy. For mothers with Anti-Ro/SSA antibodies, research suggests it may help reduce the risk of congenital heart block, especially if a previous child was affected ^[13][14]. However, it does not guarantee prevention and is an individualized decision you should make with your rheumatologist ^[2].

How Your Pregnancy and Baby Will Be Monitored

If you test positive for Anti-Ro/SSA or Anti-La/SSB antibodies, your pregnancy will be monitored closely, often by a Maternal-Fetal Medicine (MFM) specialist (an obstetrician who specializes in high-risk pregnancies) ^[2].

Monitoring typically involves serial fetal echocardiograms, which are specialized ultrasounds that focus strictly on the baby’s developing heart ^[15]. These usually take place between 16 and 26 weeks of pregnancy, which is the most critical window for heart block to develop ^[15][16]. The schedule of these ultrasounds is individualized; they may be performed weekly or every other week depending on your specific antibody levels, your clinical history, and whether you have had a previously affected child ^[15][14].

In some cases, your clinical team might instruct you on how to monitor your baby’s heart rate at home using a handheld Doppler device between ultrasound visits ^[17]. If so, this must only be done under explicit instruction from your doctor. A handheld Doppler cannot diagnose all heart rhythm problems, may miss a rapidly evolving heart block, and should never substitute for your scheduled fetal echocardiograms or professional medical assessment ^[17].

After Birth: Because neonatal lupus can involve the skin, blood, or liver, a newborn exposed to these antibodies should have a planned pediatric assessment ^[18]. This may involve an electrocardiogram (ECG) to check the baby’s heart rhythm, as well as blood counts and liver tests if clinically indicated ^[18]. Any skin rashes that develop should be protected from the sun and evaluated by a doctor.